Polycythemia vera

Polycythemia vera (PV) is an acquired myeloproliferative disorder characterized by an elevated absolute red blood cell mass caused by uncontrolled red blood cell production, frequently associated with uncontrolled white blood cell and platelet production.

Venous thrombosis

Formation of a blood clot (thrombus) inside a vein, causing the obstruction of blood flow.


Total: 6

                      


(per page)
PMID (PMCID)
27693837
(5045565)
OTHER
Massive upper gastrointestinal bleeding due to splenoportal axis thrombosis in a patient with a tested JAK2 mutation: A case report and review literature.
Macias I.
Int J Surg Case Rep. 2016;28:93-96.
The primary myeloproliferative disorders are the main cause of portal venous thrombosis and somatic mutation of Janus Kinase 2 gene (JAK2 V617F) can be found in approximately 90% of polycythemia vera, 50% of essential thrombocyrosis and 50% primary myelofibrosis.
26432562
MALE Middle Aged
A Case of Recurrent Ischemic Stroke Involving Subacute, Progressive Intracranial Cerebral Arterial Sclerosis Prior to Diagnosis with JAK2-mutated Polycythemia Vera.
Nezu T, Aoki S, Ochi K, Sugihara S, Takahashi T, Hosomi N, Maruyama H, Matsumoto M.
J Stroke Cerebrovasc Dis. 2015;24(12):e4-6.
Our report suggests that progressive intracranial arterial sclerosis and venous thrombosis of undetermined etiologies could be several initial symptoms of polycythemia vera.
17060871
MIXED_SAMPLE Middle Aged
Early experience of Budd-Chiari syndrome treatment with transjugular intrahepatic portosystemic shunt.
Lopez-Mendez E, Chavez-Tapia NC, Avila-Escobedo L, Cabrera-Aleksandrova T, Uribe M.
Ann Hepatol. 2006;5(3):157-60.
We present two cases of Budd- Chiari syndrome with severe ascites associated with polycythemia vera in first case and protein C deficiency in the second, in both cases transjugular intrahepatic portosystemic shunt were placed, with excellent control of symptoms, no mortality were observed, and just one episode of pulmonary venous thrombosis was observed.
10919043
FEMALE Adult
Successful emergency treatment with a transjugular intrahepatic portosystemic shunt for life-threatening Budd-Chiari syndrome with portal thrombotic obstruction.
Watanabe H, Shinzawa H, Saito T, Ishibashi M, Shirahata N, Miyano S, Haga H, Aoki M, Mitsuhashi H, Matsuo T, Abe T, Saito K, Yamada N, Togashi H, Takahashi T.
Hepatogastroenterology. 2000;47(33):839-41.
A 38-year-old woman with polycythemia vera was admitted in a critical condition, and Budd-Chiari syndrome complicated by portal venous thrombosis was diagnosed.
10517120
FEMALE Adult
[A 26-year-old woman with splanchnic vein thrombosis as the initial manifestation of polycythemia vera].
Escher R, Demarmels Biasiutti F.
Ther Umsch. 1999;56(9):505-8.
Association of myeloproliferative disorders, mainly polycythemia vera, with splanchnic venous thrombosis is well known and should always be looked for.
2042450
FEMALE Middle Aged
Heparin-associated thrombocytopenia in a patient with polycythemia vera: the importance of a marked drop in platelet count.
Garcia S, Cervero A, Sanchez M, Colomina P.
Acta Haematol. 1991;85(3):169-70.
The present report describes a patient with polycythemia vera who developed a severe arterial and venous thrombosis caused by systemically administered heparin.